press, concluded that terazosin was significantly more effective than placebo, whereas
finasteride was not. However, it turned out that the patients enrolled in this study had a mean …

If, however, one has determined that the symptoms (as defined by the symptom score),
urinary flow or sequelae of BPH demand treatment, then one must prescribe the most …

CONCLUSIONS In men with benign prostatic hyperplasia, terazosin improves urologic
symptoms more than placebo or finasteride and is similar in effectiveness to other [alpha] …

Benign prostatic hyperplasia (BPH) affects men with increasing frequency as they age. The
course of BPH is highly variable and not all men develop symptoms. For most patients with …

Background Men with benign prostatic hyperplasia can be treated with α1-adrenergic–
antagonist drugs that relax prostatic smooth muscle or with drugs that inhibit 5α-reductase …

Topics covered include the definition, pathology, pathophysiology, and natural history of
benign prostatic hyperplasia. Symptoms and signs are lucidly explained. Investigative …

Benign Prostatic Hyperplasia (BPH) is a common condition affecting over 50% of men as
they reach the 5th decade of their life [1]. While over half of these patients have symptoms, it …

Conclusions In men with benign prostatic hyperplasia, terazosin improves urological
symptoms more than placebo or finasteride and is similar in effectiveness to other α …

Objective: To assess whether a differential treatment response occurs with the alpha blocker
terazosin in the treatment of men with symptomatic benign prostatic hyperplasia (BPH) when …

Search 404 | Medicine Today Connect with Saturday 24 February 2024 Home Sign up for
emails Create account Subscribe Log in Home Information For readers For authors For …